Envestnet Asset Management
ATRA icon

Envestnet Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Envestnet Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,104
Closed -$14.2K – 4180
2023
Q4 		$14.2K Sell
1,104
-646
-37% -$15.1K ﹤0.01% 4027
2023
Q3 		$64.7K Buy
1,750
+567
+48% +$25.2K ﹤0.01% 3917
2023
Q2 		$47.6K Sell
1,183
-90
-7% -$5.09K ﹤0.01% 3874
2023
Q1 		$92.3K Buy
1,273
+701
+123% +$68K ﹤0.01% 3805
2022
Q4 		$46.9K Sell
572
-70
-11% -$7.29K ﹤0.01% 3873
2022
Q3 		$61K Buy
642
+224
+54% +$25.2K ﹤0.01% 3795
2022
Q2 		$81K Sell
418
-64
-13% -$10.4K ﹤0.01% 3777
2022
Q1 		$112K Buy
+482
New +$153K ﹤0.01% 3787
2018
Q3 		– Sell
-79
Closed -$72K – 1334
2018
Q2 		$72K Buy
79
+11
+16% +$11.8K ﹤0.01% 2084
2018
Q1 		$66K Buy
68
+28
+70% +$25.5K ﹤0.01% 2051
2017
Q4 		$18K Sell
40
-18
-31% -$6.65K ﹤0.01% 2537
2017
Q3 		$24K Buy
58
+3
+5% +$1.13K ﹤0.01% 2457
2017
Q2 		$19K Sell
55
-1
-2% -$385 ﹤0.01% 2599
2017
Q1 		$29K Buy
56
+4
+8% +$1.66K ﹤0.01% 2587
2016
Q4 		$19K Buy
+52
New +$22K ﹤0.01% 2672

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Envestnet Asset Management's ATRA Position: Q1 2024 in Review

Envestnet Asset Management sold out of Atara Biotherapeutics (ATRA) in Q1 2024, closing a stake of 1,104 shares — an estimated $14.2K sold.

Envestnet Asset Management first reported a position in ATRA in Q4 2016 and held it in 15 quarters. The position peaked at $112K in Q1 2022. 82 funds tracked by Wall St. Rank hold ATRA as of Q1 2024.

  • Envestnet Asset Management reported no remaining Atara Biotherapeutics position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 1,104 Atara Biotherapeutics shares in Q1 2024, an estimated $14.2K.
  • Envestnet Asset Management first reported a position in Atara Biotherapeutics in Q4 2016 and held it in 15 quarters.
  • Envestnet Asset Management's Atara Biotherapeutics position peaked at $112K in Q1 2022.
  • 82 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.